Thermal expansivity for sI and sII clathrate hydrates.

Knowledge of thermal expansivity can aid in the understanding of both microscopic and macroscopic behavior of clathrate hydrates. Diffraction studies have shown that hydrate volume changes significantly (as much as 1.5% over 50 K) as a function of temperature. It has been demonstrated previously via statistical mechanics that a minor change in hydrate volume (e.g., a 1.5% change in volume or 0.5% change in lattice parameter) can lead to a major change in the predicted hydrate formation pressure (e.g., >15% at >100 MPa for methane). Because of this sensitivity, hydrate thermal expansivity measurements, for both Structures I and II with various guests, are needed help quantify volume distortions in hydrate lattices to ensure accurate hydrate phase equilibria predictions. In addition to macroscopic phase equilibria, the thermal expansion of different hydrates can give information about the interactions between the guest molecules and the host lattice. In this work, the hydrate lattice parameters for four Structure I (C2H6, CO2, 47% C2H6 + 53% CO2, and 85% CH4 + 15% CO2) and seven Structure II (C3H8, 60% CH4 + 40% C3H8, 30% C2H6 + 70% C3H8, 18% CO2 + 82% C3H8, 87.6% CH4 + 12.4% i-C4H10, 95% CH4 + 5% C5H10O, and a natural gas mixture) systems were measured as a function of temperature. The lattice parameter measurements were combined with existing literature values. Both sI and sII hydrates, with a few exceptions, had a common thermal expansivity, independent of hydrate guest. Many guest-dependent correlations for linear thermal expansivity have been proposed. However, we present two guest-independent, structure-dependent correlations for sI and sII lattices, which have been developed to express the normalized hydrate lattice parameters (and therefore volume) as a function of temperature.

HBV DNA levels and transmission of hepatitis B by health care workers.

BACKGROUND: Laboratory-based study funded by the Research and Development Division of the Department of Health to inform the decision making on guidelines for the conduct of exposure prone procedures (EPPs) by health care workers who are hepatitis B carriers. OBJECTIVES: Define the quantity and nature of hepatitis B virus (HBV) DNA in hepatitis carriers whose serum does not contain hepatitis B e antigen (HBeAg) and in surgeons previously cleared to conduct EPPs who have transmitted HBV to their patients. STUDY DESIGN: Cross-sectional survey using HBV DNA quantification, genotyping and sequencing comparing transmitting surgeons and asymptomatic carriers. RESULTS: HBV DNA could be detected and quantified in 64.5% (136 of 211) of carriers whose serum did not contain HBeAg with a median level 3.6 log(10) copies/ml (range of 5.7 log(10) copies). Pre-core mutation appeared not to affect the HBV DNA level, however, all surgeons carried codon 28 variants and transmitted these variants to their patients. The lowest HBV DNA level in a transmitting surgeon was 4 x 10(4) copies/ml. CONCLUSIONS: Pre-core mutations are common in carriers whose serum does not contain HBeAg and do not specifically identify carriers whose HBV DNA levels are high. It was possible to define a level of virus above which transmission of hepatitis B during conduct of EPPs could not be excluded.

The effect of culture conditions on the mycelial growth and luminescence of naturally bioluminescent fungi.

The effects of temperature, light and pH on mycelial growth and luminescence of four naturally bioluminescent fungi were investigated. Cultures of Armillaria mellea, Mycena citricolor, Omphalotus olearius and Panellus stipticus were grown at 5 degrees C, 15 degrees C, 22 degrees C and 30 degrees C, under 24 h light, 12 h light/12 h dark and 24 h dark, and at a pH ranging from 3.5 to 7 in three separate experiments. Temperature and pH had a significant effect on mycelial growth and bioluminescence, however light did not. Bioluminescence and mycelial growth were optimum at 22 degrees C and pH 3-3.5, the exception being M. citricolor for which bioluminescence and growth were optimum at pH 5-6 and pH 4, respectively. With the exception of M. citricolor, bioluminescence and mycelial growth were greater under 24 h darkness. An understanding of the effect of culture conditions on mycelial growth and luminescence is necessary for the future application of bioluminescent fungi as biosensors.

Epidemiology of precore mutants of hepatitis B in the United Kingdom.

A point mutation assay was used to study the codon 28 and codon 1 precore mutant status of 310 chronic hepatitis B carriers (82 HBeAg positive and 228 HBeAg negative). Fourteen of 228 (6%) of HBeAg negative carriers had high levels of serum HBV DNA. Nine of these were explained by precore variants, three by core promoter variants, and two were not explained by recognised precore changes. Nested PCR detected serum HBV DNA in 36% (82/228) of HBeAg negative carriers and 63% (52/82) of these had precore variants. Four of 82 (4%) of the HBeAg positive carriers had precore variants, all as mixed mutant/wild type populations and evidence indicated that these carriers were seroconverting. Overall 23% (52/228) of HBeAg negative carriers had both serum HBV DNA and codon 1 or 28 precore mutations. A sexual transmission event from an HBeAg negative carrier with a relatively low serum HBV DNA level (10(4)-10(6) genome copies/ml) and only core promoter mutations was observed. Despite high rates of variant carriage in the antenatal sub-group perinatal transmission was not observed. The results of direct sequencing on 45 carriers validated the point mutation assay and also showed that codon 28 mutations were only seen in carriers with the genotype CCT at codon 15. For the Caucasian population a higher prevalence of codon 28 mutations (13/25 or 52%) than expected was seen. Liver biopsy data indicated that there was no link between the presence or absence of precore mutants and the severity of liver disease.

Detection of Legionella pneumophila using a real-time PCR hybridization assay.

A real-time PCR hybridization assay for Legionella pneumophila is described; the assay uses LightCycler (Idaho Technology) methodology to specifically detect 2.5 CFU/reaction, equivalent to 1,000 CFU/liter of starting water sample. The assay, including DNA extraction and confirmation of product identity, is completed within 90 min of receipt of a sample.

Assessing the infectivity of hepatitis B carriers.

The infectivity of 310 hepatitis B carriers (among antenatal and genitourinary medicine clinic attendees, blood donors, and patients of a liver disease unit) was assessed using three different assays: chemiluminescent molecular hybridisation assay (Murex Digene), column-based solution hybridisation assay (Abbott Genostics) and in-house polymerase chain reaction (PCR). PCR was found to be at least 100 times more sensitive (1 x 10(4) copies/mL) than Murex Digene (3.2 x 10(6) copies/mL) and Abbott Genostics (3.7 x 10(7) copies/mL). Comparison of the hepatitis B e antigen (HBeAg)/anti-HBe status and hepatitis B virus (HBV) DNA level confirmed an association between these two variables. The overall detection rate of HBV DNA by Murex Digene was 28% (87/310): 89% (73/82) in the HBeAg positive group, 10% (4/40) in the HBeAg/anti HBe negative group, and 5% (10/188) in the anti-HBe positive group. The detection rate by PCR increased to 53% (163/310): 98% (80/82) in the HBeAg positive group, 38% (15/40) in the HBeAg/anti-HBe negative group, and 36% (67/188) in the anti-HBe positive group. HBV DNA detection rates by all three assays in 97 liver disease unit patients were higher, particularly in anti-HBe positive patients, than in the cohort overall, probably reflecting a higher rate of active liver disease in these patients. HBV DNA was detected at the lowest rate in the antenatal clinic group. We suggest that HBeAg negative patients who are positive by PCR but negative by either Murex Digene or Abbott Genostics are still infectious. A cut-off serum HBV DNA level of 10(4) copies/mL is proposed, below which transmission is unlikely to occur, but further studies using quantitative PCR are needed to refine the cut-off level.

Colourimetric point mutation assay: for detection of precore mutants of hepatitis B.

A colourimetric assay for the analysis of point mutations in PCR amplified DNA fragments from hepatitis B virus (HBV) is described. The method was applied for analysis of the single point mutation in codon 28 of the precore gene of HBV, which inhibits expression of HBe antigen. The assay, which uses a microtitre plate formate, incorporates fluorescein-labelled dideoxynucleotides as opposed to radioactively-labelled deoxynucleotides used in methods described previously. Synthetic control wild type and mutant oligonucleotides were tested to optimise the reaction conditions. The assay was thus shown to yield both qualitative and quantitative data on the relative proportions of wild type and mutant sequences within a given sample. Amplicons from clinical specimens of known sequence were analysed to validate the assay. Sixteen chronic carriers of HBV were tested using the codon 28 point mutation assay, and the results were confirmed by direct sequencing. The method described is suitable for applications where point mutations are of interest.

Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.

Steroid 21-hydroxylase deficiency is the leading cause of impaired cortisol synthesis in congenital adrenal hyperplasia (CAH), with the nonclassic form (NC) comprising approximately 1% of the Caucasian population. The structure of the CYP21 gene was studied in 13 unrelated NC-CAH patients, three affected siblings, and 55 blood donors using polymerase chain reaction. In addition to the Leu-281 and Leu-30 mutations previously associated with NC-CAH, the finding of a Pro-453 to Ser mutation in exon-10 of CYP21 in the NC-CAH patients is reported. Ser-453 was found in 46.2% of unrelated NC-CAH patients, but only 7.7% and 3.6% of salt-wasting CAH patients and blood donors, respectively. In contrast to the Leu-281 and Leu-30 mutations, Ser-453 has not been previously detected in the CYP21 pseudogene (CYP21P) and, therefore, has not likely arisen by gene conversion.

Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.

We have characterized mutations in the steroid 21-hydroxylase gene (CYP21) in salt-wasting congenital adrenal hyperplasia (SW-CAH) subjects, healthy control subjects, and affected sibling pairs with SW-CAH. To identify point mutations in CYP21, we have used an improved polymerase chain reaction methodology that allows analysis of the entire CYP21 gene. In addition, we have used polymerase chain reaction to search for abnormally spliced mRNAs resulting from putatively abnormal CYP21 genes transfected into COS1 cells. We found that all 26 SW-CAH subjects from whom DNA could be completely analyzed, had mutations that could account for the 21-hydroxylase enzyme deficiency. These mutations included CYP21 gene deletion, conversion to the inactive CYP21P form, point mutations leading to amino acid substitutions or stop codons, small gene deletions, and a point mutation in intron-2 that leads to an abnormally spliced mRNA. The point mutation in intron-2 was directly shown to activate a cryptic splice site 19 basepairs from exon-3 of CYP21 and thereby cause a reading frame mutation. This CYP21 mutation was frequently found in our white SW-CAH subjects, while the frequency of this mutation was extremely low in a racially matched control population. Furthermore, affected sibling pairs shared this mutation in all cases examined. The results presented should have important applications for the prenatal diagnosis of CAH.

Getting started.

Taking the time to address both the internal and external evaluation components for every offering is without a doubt very time consuming. However, with today's focus on quality and cost effectiveness, staff development educators must take the necessary time. Further, the data can often be used to justify continuing programs that administration may want to cut, especially when the external evaluation indicates a significant change in on-the-job performance.

Getting started. Writing behavioral objectives.

Learning objectives, derived from the needs assessment, drive the rest of your offering. All learning objectives must be learner-oriented and stated in behavioral terms, describing what the learner will do to demonstrate that the objective has been achieved. Learning objectives are used as the basis for determining content, selecting learning activities, and evaluating both learner achievement and the effectiveness of the offering. Measurability is ensured by the use of observable action verbs (reminder: "will gain an understanding of ..." or "will have increased knowledge of ..." are not observable). Remember that you are designing offerings for adults, so the focus must be on applications that meet the needs of the participant. This means that you must aim at the higher levels of learning and use principles of adult learning.

Investigation by electron paramagnetic resonance spectroscopy of the molybdenum centre of respiratory nitrate reductase from Paracoccus denitrificans.

The molybdenum centre of respiratory nitrate reductase from Paracoccus denitrificans has been investigated by e.p.r. spectroscopy of Mo(V). In common with the centres of the analogous enzymes from Escherichia coli and Pseudomonas aeruginosa, it undergoes a pH- and anion-dependent transition between two different e.p.r. signal-giving species. Comparison of the relevant e.p.r. parameters extracted with the help of computer simulations reveals ligation of the metal in the active centres of the three enzymes to be identical.

Respiratory nitrate reductase from Paracoccus denitrificans. Evidence for two b-type haems in the gamma subunit and properties of a water-soluble active enzyme containing alpha and beta subunits.

1. The b-type haem centres of the three (alpha, beta and gamma) subunit nitrate reductase from Paracoccus denitrificans have been analysed by redox potentiometry. Two components were identified with mid-point potentials +95 mV and +210 mV. 2. Washing, in the absence of Mg2+ ions, of cytoplasmic membrane vesicles from P. denitrificans promoted selective release of nitrate reductase activity. The released enzyme was purified by chromatography and shown to contain alpha and beta, but not gamma polypeptides. A haem spectrum was absent, consistent with the lack of the gamma subunit. The alpha and beta polypeptides of the water-soluble nitrate reductase had molecular masses that were identical to those of the detergent-purified enzyme and also of the nitrate reductase in cytoplasmic membranes. This observation, together with the failure of protease inhibitors to prevent release from the membrane, indicates that the release is not related to limited proteolysis of the alpha and/or beta polypeptides. The relative molecular mass of the water-soluble alpha beta enzyme was estimated to be approximately 200,000. 3. The water-soluble nitrate reductase was released from intact inverted cytoplasmic membrane vesicles as judged by loss of NADH-NO3- reductase activity and retention by the vesicles after washing of uncoupler-sensitive NADH-oxidase activity. These observations show that alpha and beta polypeptides, and therefore the active site for nitrate reduction, are located on the cytoplasmic side of the membrane. 4. Attempts to reverse the nitrate reductase activity of the enzyme, using nitrate as reductant plus ferricyanide or chlorate as tested oxidants, were unsuccessful. The implications for the mechanism of the enzyme are discussed.